• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015年国际肝癌协会(ILCA)第九届年会

The 9th Annual Conference of the International Liver Cancer Association (ILCA) 2015.

作者信息

Marquardt Jens U, Galle Peter R

机构信息

Department of Internal Medicine, University Medical Center, Johannes Gutenberg University Mainz, Germany.

Bioinformatics Core Facility Mainz (Bium-Mz), University Medical Center, Johannes Gutenberg University Mainz, Germany.

出版信息

Hepat Oncol. 2016 Jan;3(1):9-12. doi: 10.2217/hep.15.39. Epub 2015 Nov 30.

DOI:10.2217/hep.15.39
PMID:30191023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6095313/
Abstract

The 9th International Liver Cancer Association Annual Conference was held from 4th to 6th September 2015 in Paris, France, and attracted a record breaking 900 participants from 51 different countries and 386 submitted abstracts from scientists around the globe. The congress provided a comprehensive overview of current developments in primary liver cancers (i.e., hepatocellular carcinoma and cholangiocarcinoma) and covered a broad range of topics from basic science to clinical studies. Following the success of immunotherapies in recent years, a preconference workshop on immunopathogenesis and immunotherapy in hepatocellular carcinoma also took place. This report will provide a subjective summary of selected abstracts presented at the conference.

摘要

第九届国际肝癌协会年会于2015年9月4日至6日在法国巴黎举行,吸引了来自51个不同国家的900名参会者,创下纪录,全球科学家提交了386篇摘要。此次大会全面概述了原发性肝癌(即肝细胞癌和胆管癌)的当前进展,涵盖了从基础科学到临床研究的广泛主题。继近年来免疫疗法取得成功之后,还举办了一场关于肝细胞癌免疫发病机制和免疫疗法的会前研讨会。本报告将对会议上展示的部分摘要进行主观总结。

相似文献

1
The 9th Annual Conference of the International Liver Cancer Association (ILCA) 2015.2015年国际肝癌协会(ILCA)第九届年会
Hepat Oncol. 2016 Jan;3(1):9-12. doi: 10.2217/hep.15.39. Epub 2015 Nov 30.
2
Reports from the International Liver Cancer Association (ILCA) congress 2014.2014 年国际肝癌协会(ILCA)大会报告。
J Hepatol. 2015 Feb;62(2):477-82. doi: 10.1016/j.jhep.2014.11.015. Epub 2014 Nov 22.
3
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.暴风雨前的平静:国际肝癌协会2015年大会报告——第一部分
Future Oncol. 2016 Feb;12(3):281-4. doi: 10.2217/fon.15.323. Epub 2016 Jan 18.
4
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.暴风雨前的宁静:2015年国际肝癌协会大会报道 - 第二部分
Future Oncol. 2016 Feb;12(3):285-8. doi: 10.2217/fon.15.324. Epub 2016 Jan 18.
5
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.克罗地亚皮肤性病学会史——克罗地亚医学协会及《克罗地亚皮肤性病学学报》重要信息概述
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
6
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.首届卡塔尔重症监护会议及其《卡塔尔医学杂志》特刊——一个重要的里程碑。
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
7
The 2nd United Kingdom Extracellular Vesicle Forum Meeting Abstracts: 15 December 2015, Hadyn Ellis Building, Cardiff University.第二届英国细胞外囊泡论坛会议摘要:2015 年 12 月 15 日,卡迪夫大学海登·埃利斯大楼。
J Extracell Vesicles. 2016 Feb 23;5:30924. doi: 10.3402/jev.v5.30924. eCollection 2016.
8
Conference Report: European Society for Medical Oncology Congress 2022.会议报告:2022年欧洲医学肿瘤学会大会
Rare Tumors. 2023 Mar 3;15:20363613231162474. doi: 10.1177/20363613231162474. eCollection 2023.
9
[The 9th international conference of the asian clinical oncology society in Japan after a twenty year interval--what is the standpoint of Japan in Asia ?].[时隔二十年在日本召开的第九届亚洲临床肿瘤学会国际会议——日本在亚洲处于何种立场?]
Gan To Kagaku Ryoho. 2011 Jun;38(6):885-91.
10
The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida: A summary of topics and trends.2019 年精神分裂症国际研究学会会议,4 月 10 日至 14 日,佛罗里达州奥兰多:主题和趋势概述。
Psychiatry Res. 2020 Feb;284:112672. doi: 10.1016/j.psychres.2019.112672. Epub 2019 Nov 9.

本文引用的文献

1
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.人类肝细胞癌中反复出现的 AAV2 相关插入性突变。
Nat Genet. 2015 Oct;47(10):1187-93. doi: 10.1038/ng.3389. Epub 2015 Aug 24.
2
Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.肝癌肿瘤基因组学:临床应用的机遇与困境
Hepat Oncol. 2015;2(1):79-93. doi: 10.2217/hep.14.24.
3
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.雷莫芦单抗二线治疗索拉非尼一线治疗后晚期肝细胞癌患者(REACH):一项随机、双盲、多中心、III 期临床试验。
Lancet Oncol. 2015 Jul;16(7):859-70. doi: 10.1016/S1470-2045(15)00050-9. Epub 2015 Jun 18.
4
From non-A, non-B hepatitis to hepatitis C virus cure.从非 A、非 B 型肝炎到丙型肝炎病毒治愈。
J Hepatol. 2015 Apr;62(1 Suppl):S87-99. doi: 10.1016/j.jhep.2015.02.006.
5
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.肝细胞癌的外显子组测序鉴定出新的突变特征和潜在治疗靶点。
Nat Genet. 2015 May;47(5):505-511. doi: 10.1038/ng.3252. Epub 2015 Mar 30.
6
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.肝癌患者基于免疫治疗的当前概念:从基础科学到新的治疗方法。
Gut. 2015 May;64(5):842-8. doi: 10.1136/gutjnl-2014-307990. Epub 2015 Feb 9.
7
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.跨种族肝细胞癌基因组的突变特征。
Nat Genet. 2014 Dec;46(12):1267-73. doi: 10.1038/ng.3126. Epub 2014 Nov 2.
8
Molecular pathogenesis of intrahepatic cholangiocarcinoma.肝内胆管癌的分子发病机制
J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):101-13. doi: 10.1002/jhbp.155. Epub 2014 Sep 1.
9
Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.检测纤维板层肝细胞癌中反复出现的 DNAJB1-PRKACA 嵌合转录本。
Science. 2014 Feb 28;343(6174):1010-4. doi: 10.1126/science.1249484.
10
Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.一种识别聚糖蛋白 3 硫酸乙酰肝素链的人源抗体对肝癌治疗中 Wnt 信号通路的抑制作用。
Hepatology. 2014 Aug;60(2):576-87. doi: 10.1002/hep.26996. Epub 2014 Jun 18.